Dow Up0.04% Nasdaq Up0.89%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
20.93 Up 0.10(0.48%) 4:00PM EST
|After Hours : 20.76 Down 0.17 (0.81%) 7:41PM EST - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 1,101   592   416   620  
Cost of Revenue -   -   -   -  
Gross Profit 1,101   592   416   620  
Operating Expenses
Research Development26,186  24,099  27,070  17,804  
Selling General and Administrative5,004  4,787  4,582  4,677  
Non Recurring -   -   -   -  
Others253  254  253  253  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (30,342) (28,548) (31,489) (22,114)
Income from Continuing Operations
Total Other Income/Expenses Net2,261  274  1,586  137  
Earnings Before Interest And Taxes(28,081)(28,274)(29,903)(21,977)
Interest Expense -   -   -  85  
Income Before Tax(28,081)(28,274)(29,903)(22,062)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(28,081)(28,274)(29,903)(22,062)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (28,081) (28,274) (29,903) (22,062)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (28,081) (28,274) (29,903) (22,062)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.